Navigation Links
Protective footwear for diabetics at a high-street price
Date:5/26/2009

Diabetes rates have risen sharply in developed countries in the wake of the obesity epidemic, and an estimated 30 million Europeans live with the condition. Foot problems are the most common cause of admission to hospital for diabetics, who are at risk of serious complications such as nerve damage and problems with the blood supply to their feet. Both conditions can lead to slow-healing wounds and foot ulcers which, if they get infected and become gangrenous, can lead to amputation.

According to the International Diabetes Federation, most cases of foot ulcers and amputations can be prevented by good foot care and wearing appropriate, properly fitting shoes that don't rub the feet or create pressure spots. Studies show that unsuitable footwear contributes to a significant increase in foot complications and is linked to 60-80% of all cases of foot damage.

The idea for EUREKA Project E! 2923 DIASHOE came from Professor Petr Hlavacek, Head of the Institute of Proteins and Leather Technology at the Tomas Bata University in the Czech Republic. He approached Czech footwear manufacturer and retailer Bata to suggest collaborating on developing a new generation of affordable prophylactic footwear for diabetics, designed to protect their feet and slow down and prevent unnecessary or irreversible damage.

Led by Bata, the four-year project pulled together the expertise of university researchers, diabetes experts and orthopaedic footwear specialists from the Czech Republic, Austria, Germany and Italy.

Getting the measure of the problem

The design and development phase of the project involved developing a prototype shoe last, along with specialised soles, insoles and antibacterial linings. Constructing and refining the shoe last required, for comparison purposes, analysis of the feet of both diabetics and non-diabetics, plus thousands of meticulous measurements which were performed by researchers and students at the Tomas Ba
'/>"/>

Contact: Jana Vaskova
vaskova@bata.cz
004-207-316-18730
EUREKA
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UMMS researchers isolate first neuroprotective gene in patients with amyotrophic lateral sclerosis
2. HIV dearms protective protein in cells
3. Scientists unlock the secrets of C. difficiles protective shell
4. Infection blocks lungs protective response against tobacco smoke
5. When our protective armor shows weakness
6. Diabetics on high-fiber diets might need extra calcium, report UT Southwestern researchers
7. Fear of hypoglycemia a barrier to exercise for type 1 diabetics
8. Apelin to rescue diabetics
9. HIV pays a price for invisibility
10. Tom Cruise smile comes with a sunburn price
11. World fertilizer prices drop dramatically after soaring to all-time highs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... planning grant will help establish the Center for Advanced ... University of Illinois at Urbana-Champaign and Worcester Polytechnic Institute ... to research in drying moist, porous materials such as ... chemical products; textiles; and biopharmaceuticals," said Hao Feng, a ... nutrition and the Illinois site director. , According to ...
(Date:5/20/2013)... the University of Bristol and published online today in ... on how the brain and inner ear developed in ... Earth Sciences, together with Tom Hbner from the Niederschsische ... million year old dinosaurs. , The two palaeontologists studied ... : a very young (juvenile) individual of approximately ...
(Date:5/19/2013)... white men and women of European descent inherit common ... toe deformities, including hammer or claw toe. Findings from ... of foot disorders in humansappear in Arthritis Care ... behalf of the American College of Rheumatology (ACR). ... of older adults have foot disorders which may limit ...
Breaking Biology News(10 mins):NSF approves planning grant for Center for Advanced Research in Drying 2Fossil brain teaser 2Blame your parents for bunion woes 2
... Highlights: Advanced technologies create ... Radio was integrated easily with Army,s cellular biometric network ... Harris Corporation,s (NYSE: HRS ... infrastructure for various mission scenarios at the Empire Challenge 2011 ...
... 2011 Ceelox, Inc., (OTCBB: CELO), (the "Company"), proudly ... the U.S. Patent Office. The patent, U.S. Patent Number ... Encryption And Decryption" provides the ability to biometrically enable ... data.  Ceelox, latest patent is unique in that it ...
... study from scientists at Queen Mary, University of London, sheds ... go through major surgery, can suffer organ damage in parts ... The study, published today in Nature Immunology *, ... out of blood vessels to defend damaged organs against injury ...
Cached Biology News:Harris Corporation's Highband Networking Radio Provides Mobile, Wideband Communications for Empire Challenge 2011 2Harris Corporation's Highband Networking Radio Provides Mobile, Wideband Communications for Empire Challenge 2011 3Ceelox Vault Patent Issued 2Ceelox Vault Patent Issued 3Rogue blood cells may contribute to post-surgery organ damage 2
(Date:5/21/2013)... Bed bugs have become so widespread in ... many turn to chemical-based pesticides for help to completely get ... risks those solutions present, the company advised the public to ... , According to My Cleaning Products, chemical-based pesticides are ... be. It shared that the pests have already developed immunity ...
(Date:5/21/2013)... Inflamax scientists worked closely with ... design the study, which will provide critical insight ... used in the study of allergy treatments, the ... (NAC) models. Although both the models are well ... no direct comparison between the allergic responses evoked ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/21/2013)... 2013 Clinovo's new “CDISC Standards: ... program starting on June 11th, 2013. The TechTrainings are ... reach the next step in their professional career. The ... Alto, and streamed online. , Taught by Sy Truong, ... new “CDISC Standards: Theory and Application” class will give ...
Breaking Biology Technology:New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Clinovo Launches TechTrainings on CDISC Standards 2
... onset seizure reduction, proven tolerability, and ... - Keppra XR(TM) is built on ... regulated information:,UCB announced today that the U.S. Food and Drug ... as,an add-on to other antiepileptic treatments for people with partial-onset,seizures ...
... 12 Exosome Diagnostics, Inc. today,announced the appointment ... In this role, Dr. Skog will oversee the ... blood-based diagnostics that can,identify cancer-specific genetic mutations., ... of Exosome Diagnostics,core technology that has been licensed ...
... - Upfront, milestone payments and promotional investment totaling up to ... ... 12 CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... Ranexa(R) (ranolazine prolonged release,tablets) in Europe and other countries to ...
Cached Biology Technology:Video: Keppra XR(TM) Approved in the U.S. 2Video: Keppra XR(TM) Approved in the U.S. 3Video: Keppra XR(TM) Approved in the U.S. 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 2CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 3CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 5
... research laboratory, the revolutionary Luminex 100 System ... and in real time enhancing your operational ... includes the Luminex 100, the XY Platform, ... which enables you to simultaneously assay up ...
... is a compact analysis system for the clinical ... a controller, advanced digital signal processing and a ... system includes the Luminex 100, the XY Platform, ... file at the FDA, and partner kits that ...
... quality source of amino acids and ... of casein. It is recommended for ... been used in antibiotics, toxins and ... For microbiology pH6.8 0.5 at 25 ...
... peptone, used in media ... bacterial toxins, and for ... with high nutritional requirements ... Pasteurella, Salmonella and Staphylococcus ...
Biology Products: